(RGNX) Regenxbio - Performance -24.2% in 12m
RGNX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-85.10%
#156 in Peer-Group
Rel. Strength
21.33%
#5843 in Stock-Universe
Total Return 12m
-24.21%
#81 in Peer-Group
Total Return 5y
-77.30%
#90 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 14.39 USD |
| 52 Week Low | 5.31 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 45.71 |
| Buy/Sell Signal +-5 | -1.20 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RGNX (-24.2%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: RGNX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RGNX
| Total Return (including Dividends) | RGNX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.47% | 3.18% | 4.52% |
| 3 Months | 17.34% | 2.36% | 10.25% |
| 12 Months | -24.21% | -10.75% | 14.16% |
| 5 Years | -77.30% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | RGNX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -58.7% | 30.9% | 79.1% |
| 3 Months | 56.2% | 63.2% | 91.7% |
| 12 Months | -69.1% | -83.8% | 44% |
| 5 Years | -93.3% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th34.50 | -9.35% | -10.51% |
| 3 Month | %th67.00 | 14.63% | 6.43% |
| 12 Month | %th60.00 | -15.08% | -33.61% |
| 5 Years | %th56.00 | -69.93% | -89.53% |
FAQs
Does Regenxbio (RGNX) outperform the market?
No,
over the last 12 months RGNX made -24.21%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months RGNX made 17.34%, while XBI made 2.36%.
Performance Comparison RGNX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RGNX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.3% | -11% | 10.9% | -38% |
| US NASDAQ 100 | QQQ | 3.7% | -12% | 9.5% | -39% |
| German DAX 40 | DAX | 3.5% | -6.8% | -4.3% | -55% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5% | -9% | 14.9% | -41% |
| Hongkong Hang Seng | HSI | 4% | -13.3% | -6.3% | -60% |
| India NIFTY 50 | INDA | 3.9% | -8.8% | 9.9% | -24% |
| Brasil Bovespa | EWZ | 5% | -10% | -10.7% | -35% |
RGNX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.1% | -13.4% | 4.6% | -52% |
| Consumer Discretionary | XLY | 4.8% | -8.4% | 18.9% | -45% |
| Consumer Staples | XLP | 7.8% | -5.2% | 12% | -33% |
| Energy | XLE | 7.6% | -11% | 13.5% | -21% |
| Financial | XLF | 4.5% | -9% | 7.7% | -52% |
| Health Care | XLV | 5.4% | -8.1% | 17.6% | -18% |
| Industrial | XLI | 4.7% | -9.6% | 4.1% | -48% |
| Materials | XLB | 5.7% | -8.8% | 10.1% | -27% |
| Real Estate | XLRE | 9% | -6% | 12.6% | -36% |
| Technology | XLK | 3.5% | -14.9% | 8.7% | -35% |
| Utilities | XLU | 6.6% | -7.5% | 7.2% | -48% |
| Aerospace & Defense | XAR | 2.4% | -16.1% | -10.2% | -76% |
| Biotech | XBI | 5.8% | -9.7% | 23.7% | -13% |
| Homebuilder | XHB | 5.7% | -10.4% | 21.4% | -25% |
| Retail | XRT | 6.5% | -8.6% | 18.3% | -31% |
RGNX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.8% | -15.5% | 18.1% | -14% |
| Natural Gas | UNG | 8.5% | -9.9% | 24.3% | -24% |
| Gold | GLD | 9.9% | -5% | -9.1% | -64% |
| Silver | SLV | 7.8% | -14.1% | -7.4% | -46% |
| Copper | CPER | 3.4% | -15.1% | -7.5% | -40% |
RGNX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6% | -8.3% | 14.7% | -25% |
| iShares High Yield Corp. Bond | HYG | 6.3% | -8% | 11.4% | -35% |